SGH
Sivik Global Healthcare Portfolio holdings
AUM
$127M
1-Year Est. Return
20.09%
This Fund
S&P 500
1 Year Est. Return
+20.09%
AUM
$205M
AUM Growth
+$14.3M
(+7.5%)
Holding
65
Top Buys
| 1 | +$4.19M | |
| 2 | +$3.84M | |
| 3 | +$3.81M | |
| 4 |
AstraZeneca
AZN
|
+$3.51M |
| 5 |
Biogen
BIIB
|
+$3.27M |
Top Sells
| 1 | +$4.64M | |
| 2 | +$4.04M | |
| 3 | +$3.94M | |
| 4 |
West Pharmaceutical
WST
|
+$3.94M |
| 5 |
Quest Diagnostics
DGX
|
+$3.81M |
Sector Composition
| 1 | Healthcare | 86.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
State Street SPDR S&P Biotech ETF
XBI
$8.65B
| $27.4M | 13.39% |
225,000
-25,000
|
|
||
2
Eli Lilly
LLY
$820B
| $7.52M | 3.67% |
7,000
-3,000
|
|
||
3
Tenet Healthcare
THC
$16.5B
| $7.45M | 3.64% |
37,500
+2,500
|
|
||
4
McKesson
MCK
$102B
| $7.38M | 3.6% |
9,000
+2,000
|
|
||
5
HCA Healthcare
HCA
$106B
| $7M | 3.42% |
15,000
-2,000
|
|
||
6
Thermo Fisher Scientific
TMO
$173B
| $6.95M | 3.39% |
12,000
-2,000
|
|
||
7
Cardinal Health
CAH
$48.2B
| $6.68M | 3.26% |
32,500
-5,000
|
|
||
8
Boston Scientific
BSX
$97.6B
| $6.67M | 3.26% |
70,000
|
|
||
9
Vertex Pharmaceuticals
VRTX
$111B
| $6.24M | 3.05% |
13,770
-230
|
|
||
10
Universal Health Services
UHS
$11.1B
| $6.11M | 2.98% |
28,000
|
|
||
11
Cencora
COR
$60.6B
| $6.08M | 2.97% |
18,000
-2,000
|
|
||
12
Intuitive Surgical
ISRG
$170B
| $5.66M | 2.77% |
10,000
-3,000
|
|
||
13
Encompass Health
EHC
$10.1B
| $5.31M | 2.59% |
50,000
+15,000
|
|
||
14
Danaher
DHR
$126B
| $5.26M | 2.57% |
23,000
-12,000
|
|
||
15
Abbott
ABT
$161B
| $5.01M | 2.45% |
40,000
+2,500
|
|
||
16
Agilent Technologies
A
$32.3B
| $4.76M | 2.33% |
35,000
+2,000
|
|
||
17
AbbVie
ABBV
$355B
| $4.57M | 2.23% |
20,000
|
|
||
18
Stryker
SYK
$126B
| $4.57M | 2.23% |
13,000
|
|
||
19
Medtronic
MDT
$108B
| $4.32M | 2.11% |
45,000
-15,000
|
|
||
20
Mettler-Toledo International
MTD
$25.6B
| $4.18M | 2.04% |
+3,000
|
|
||
21
Smith & Nephew
SNN
$13.6B
| $4.1M | 2% |
125,000
-35,000
|
|
||
22
Repligen
RGEN
$6.43B
| $4.1M | 2% |
25,000
-2,500
|
|
||
23
UnitedHealth
UNH
$322B
| $3.96M | 1.93% |
12,000
|
|
||
24
Becton Dickinson
BDX
$44B
| $3.88M | 1.89% |
+20,000
|
|
||
25
Humana
HUM
$25.8B
| $3.84M | 1.88% |
15,000
-10,000
|
|